HemoShear Therapeutics Funding: $53M Raised, Series A (2021)
HemoShear Therapeutics is based in Charlottesville, Virginia. It has raised $53M in total funding. Latest round: Series A.
HemoShear Therapeutics funding overview
HemoShear Therapeutics is based in Charlottesville, Virginia. HemoShear Therapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2021. The round record for HemoShear Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Suvretta Capital, Janus Henderson Investors, Adage Capital Management LP. 3 distinct backers are named across the disclosed rounds.
HemoShear Therapeutics at a glance
Total raised
$53M
Latest round
Series A
Latest round date
February 2021
Headquarters
Charlottesville, Virginia
Notable investors
Suvretta Capital, Janus Henderson Investors, Adage Capital Management LP
Frequently asked about HemoShear Therapeutics funding
How much has HemoShear Therapeutics raised?
HemoShear Therapeutics has raised $53M in total disclosed funding across the rounds on record.
Who has invested in HemoShear Therapeutics?
Suvretta Capital, Janus Henderson Investors, Adage Capital Management LP are named among the investors backing HemoShear Therapeutics.
What was the latest HemoShear Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2021.
Where is HemoShear Therapeutics based?
HemoShear Therapeutics is based in Charlottesville, Virginia.
When did HemoShear Therapeutics last raise?
The last disclosed HemoShear Therapeutics round closed in February 2021 at Series A.
HemoShear Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Charlottesville below to benchmark round size and investor mix.
